What does CUSIP 98420N105 represent in this 13F holders report?

CUSIP 98420N105 is the security identifier for XENE - Xenon Pharmaceuticals Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held XENE - Xenon Pharmaceuticals Inc. - Common Stock in Q4 2022?

157 institutional investors reported XENE - Xenon Pharmaceuticals Inc. - Common Stock for Q4 2022. Use the holders table for investor-level position and value details.

Xenon Pharmaceuticals Inc. - Common Stock (XENE)

CUSIP: 98420N105

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / Common Stock
Total 13F shares: 60,466,775
Total 13F value: $2,384,173,156
Share change: +932,907
Put/Call ratio: 16%
SEC-reported price per share: $39.43
Number of holders: 157
Value change: +$38,699,727
Number of buys: 80
Number of sells: 61
Shares outstanding: 95,032,800

Security key

98420N105

Report period

Q4 2022

Institutions

157

Top holders

XENE full security history Ownership snapshot Full 13F holder table Xenon Pharmaceuticals Inc. SEC filings Xenon Pharmaceuticals Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of XENE - Xenon Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Avoro Capital Advisors LLC

Disclosed value leader

Avoro Capital Advisors LLC

Comparable rows

15/15

Latest evidence

30 Sep 2022

13F Lead comparable stake: 5.2% Showing 1-6 of 15 holder rows.

Quick read

Avoro Capital Advisors LLC leads the comparable SEC ownership view at 5.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Avoro Capital Advisors LLC's linked filing trail.

Comparable ownership Top 5

Avoro Capital Advisors LLC 5.2%

FMR LLC 4.9%

DRIEHAUS CAPITAL MANAGEMENT LLC 4.7%

MARSHALL WACE, LLP 3%

Polar Capital Holdings Plc 2.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Avoro Capital Advisors LLC	13F Company 13F	5.2%	$176,890,000 4,900,000 shares	—	30 Sep 2022
FMR LLC	13F Company 13F	4.9%	$168,578,000 4,669,759 shares	—	30 Sep 2022
DRIEHAUS CAPITAL MANAGEMENT LLC	13F Company 13F	4.7%	$162,595,000 4,504,020 shares	—	30 Sep 2022
MARSHALL WACE, LLP	13F Company 13F	3%	$101,480,000 2,811,095 shares	—	30 Sep 2022
Polar Capital Holdings Plc	13F Company 13F	2.8%	$96,124,000 2,662,722 shares	—	30 Sep 2022
Redmile Group, LLC	13F Company 13F	2.5%	$85,579,000 2,370,614 shares	—	30 Sep 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

157

60,466,775

Rows available

157

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

151

Q4 2022 holders

157

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 value	Q4 2022 value	Value change	Value Chg %